GSK-2793660 is an irreversible, orally bioavailable Cathepsin C (CTSC) inhibitor. This dipeptidyl compound has been investigated in preclinical studies for bronchiectasis, where it demonstrated activity in reducing neutrophil serine protease activity in relevant in vitro and in vivo models.
Molecular Weight:
357.45
CAS Number:
[1613458-70-0]
Formula:
C20H27N3O3
Target:
Others,Cysteine Protease
* VAT and and shipping costs not included. Errors and price changes excepted